Search

everythinglearnresearchcommunity

for

Search:↓

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

The new skin model can predict how chemicals might cause skin allergies.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Gamma/delta T cells help defend skin against heavy metals.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Innovative methods are reducing animal testing and improving biomedical research.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Feline cutaneous lymphocytosis is likely reactive, while canine cutaneous lymphocytosis needs more study to understand its nature.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Hair transplants can risk reactivating lichen planopilaris, a scarring hair loss condition.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Talquetamab may cause hair loss and skin issues.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.